NF-κB1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-κB2 p100 to p52 in quiescent mature B cells Journal Article


Authors: Hatada, E. N.; Do, R. K. G.; Orlofsky, A.; Liou, H. C.; Prystowsky, M.; MacLennan, I. C. M.; Caamano, J.; Chen-Kiang, S.
Article Title: NF-κB1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-κB2 p100 to p52 in quiescent mature B cells
Abstract: B lymphocyte stimulator (BLyS), a TNF family protein essential for peripheral B cell development, functions primarily through attenuation of B cell apoptosis. In this study, we show that BLyS activates NF-κB through both classical and alternative pathways with distinct kinetics in quiescent mature B cells. It rapidly and transiently enhances the p50/p65 DNA binding activity and induces phosphorylation of IκBα characteristic of the classical NF-κB pathway, albeit maintaining IκBα at a constant level through ongoing protein synthesis and proteasome-mediated destruction. With delayed kinetics, BLyS promotes the processing of p100 to p52 and sustained formation of p52/RelB complexes via the alternative NF-κB pathway. p50 is dispensable for p100 processing. However, it is required to mediate the initial BLyS survival signals and concomitant activation of Bcl-xL in quiescent mature B cells ex vivo. Although also a target of BLyS activation, at least one of the A1 genes, A1-a, is dispensable for the BLyS survival function. These results suggest that BLyS mediates its survival signals in metabolically restricted quiescent B cells, at least in part, through coordinated activation of both NF-κB pathways and selective downstream antiapoptotic genes.
Keywords: signal transduction; protein phosphorylation; unclassified drug; nonhuman; protein analysis; animal cell; mouse; animals; mice; mice, knockout; cell survival; complex formation; apoptosis; proteasome; cell maturation; protein; membrane proteins; immunoglobulin enhancer binding protein; cell differentiation; transcription factor rela; bcl-x protein; phosphorylation; mice, inbred c57bl; b lymphocyte; dna; protein processing; protein processing, post-translational; tumor necrosis factor-alpha; protein synthesis; nf-kappa b; cell isolation; immunoblotting; protein biosynthesis; up-regulation; dna binding; proto-oncogene proteins c-bcl-2; synaptotagmin; tumor necrosis factor; i kappa b; interphase; i-kappa b proteins; protein p50; protein p52; cell kinetics; b-cell activating factor; priority journal; article; b-lymphocyte subsets; protein blys; protein p100; ribonuclease protection assay; nf-kappa b p50 subunit; nf-kappa b p52 subunit
Journal Title: Journal of Immunology
Volume: 171
Issue: 2
ISSN: 0022-1767
Publisher: The American Association of Immunologists, Inc  
Date Published: 2003-07-01
Start Page: 761
End Page: 768
Language: English
PUBMED: 12847243
PROVIDER: scopus
DOI: 10.4049/jimmunol.171.2.761
DOI/URL:
Notes: Export Date: 12 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kinh Gian Do
    258 Do